Filing Details

Accession Number:
0001209191-11-033934
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-09 20:09:02
Reporting Period:
2011-06-07
Filing Date:
2011-06-09
Accepted Time:
2011-06-09 19:09:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406652 C Douglas Bryant 10165 Mckellar Court
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-07 5,000 $14.96 169,396 No 4 P Direct
Common Stock Acquisiton 2011-06-08 5,000 $15.18 174,396 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The weighted average purchase price for these transactions was $14.964 per share, with a range of $14.80 to $15.159 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
  2. The weighted average purchase price for these transactions was $15.177 per share, with a range of $15.14 to $15.189 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.